Jianlong Yuan

Dr. Jianlong Yuan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Genes and Environment
Verified
Journal Article
Open access
PDF file
HWHuizeng Wang
Huizeng Wang
BLBingchun Liu
Bingchun Liu
HCHong Chen
Hong Chen
PXPeixin Xu
Peixin Xu
HXHuiting Xue
Huiting Xue
JYJianlong Yuan
Jianlong Yuan
Benzo(a)pyrene (BaP), the earliest and most significant carcinogen among polycyclic aromatic hydrocarbons (PAHs), has been found in foods, tobacco smoke, and automobiles exhaust, etc. Exposure to BaP induced DNA damage directly, or oxidative stress-related damage, resulting in cell apoptosis and carcinogenesis in human respiratory system, digestive system, reproductive system, etc. Moreover, BaP triggered genome-wide epigenetic alterations by methylation, which might cause disturbances in regulation of gene expression, and thereby induced cancer. It has been proved that BaP reduced genome-wide DNA methylation, and activated proto-oncogene by hypomethylation in the promoter region, but silenced tumor suppressor genes by promoter hypermethylation, resulting in cancer initiation and progression. Here we summarized the changes in DNA methylation in BaP exposure, and revealed the methylation of DNA plays a role in cancer development. Graphical Abstract

6 July 2024 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
PXPeixin Xu
Peixin Xu
BLBingChun Liu
BingChun Liu
HCHong Chen
Hong Chen
HWHuizeng Wang
Huizeng Wang
XGXin Guo
Xin Guo
JYJianlong Yuan
Jianlong Yuan

16 June 2025 in Toxicology
Verified
Journal Article
Closed access
YWYurong Wang
Yurong Wang
PXPeixin Xu
Peixin Xu
HCHong Chen
Hong Chen
XGXin Guo
Xin Guo
JGJing Gao
Jing Gao
JYJianlong Yuan
Jianlong Yuan

10 May 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
HCHong Chen
Hong Chen
BLBingchun Liu
Bingchun Liu
PXPeixin Xu
Peixin Xu
HWHuizeng Wang
Huizeng Wang
XGXin Guo
Xin Guo
JYJianlong Yuan
Jianlong Yuan
Due to exposure factors such as industrial exhaust, sewage discharge, pesticide runoff, automobile exhaust, and fuel combustion, environmental toxicants are widely present in daily life. Organisms are exposed to these environmental toxicants through contaminated air, food, and drinking water, and these environmental toxicants enter the human body and cause cytotoxicity and diseases through various pathways. As a new cell death mode that is different from cell necrosis, apoptosis, and autophagy, ferroptosis are mainly dysregulation of intracellular iron metabolism, lipid metabolism disorders, and the dysregulation of the antioxidant defense system, leading to lipid peroxidation and ultimately to the rupture of the cell membrane, damage, and cell death. Studies have shown that environmental toxicants induce a series of diseases, such as digestive diseases, urinary diseases, respiratory diseases, neurological disorders, and reproductive diseases, through the above mechanisms. We elaborate the mechanism of common environmental toxicants in inducing ferroptosis and the related systemic diseases mediated through the ferroptosis to provide the theoretical basis for preventing and treating environmental toxicant-related diseases. Nonetheless, our understanding of ferroptosis remains incomplete. For example, mechanisms and methods for the selective control of ferroptosis remain elusive, elucidating these mechanisms and strategies may be critical for leveraging knowledge of ferroptosis to treat related diseases.

21 November 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
XGXin Guo
Xin Guo
BLBingchun Liu
Bingchun Liu
PXPeixin Xu
Peixin Xu
HCHong Chen
Hong Chen
JGJing Gao
Jing Gao
JYJianlong Yuan
Jianlong Yuan
Reproductive system disorders significantly contribute to infertility, and traditional or conventional treatments often have limited efficacy in addressing this issue. In recent years, stem cell therapy has emerged as an alternative therapeutic strategy owing to its various advantages. Human umbilical cord mesenchymal stem cells (hUC-MSCs) are pivotal in tissue repair owing to their robust proliferative capacity, potent immunomodulatory effects, low immunogenicity, and paracrine actions. Extracellular vesicles (EVs), the primary mediators of paracrine functions, exhibit therapeutic effects similar to those of hUC-MSCs. Consequently, numerous researchers have investigated the application of hUC-MSCs and their EVs in treating reproductive disorders. These cells have the potential to restore fertility by mitigating oxidative stress, excessive autophagy, and ferroptosis in tissues, while promoting the expression of anti-inflammatory factors and vascular remodeling. However, hUC-MSCs present significant limitations compared to EVs, including higher tumorigenicity and low infusion efficiency. Consequently, EVs may emerge as the primary alternative therapy, while hUC-MSCs hold promise as a therapeutic option with potential applications in regenerative medicine.

12 June 2026 in iScience
Verified
Journal Article
Open access
XLXin Li
Xin Li
HCHong Chen
Hong Chen
PXPeixin Xu
Peixin Xu
XGXin Guo
Xin Guo
JGJing Gao
Jing Gao
JYJianlong Yuan
Jianlong Yuan
Exosomes (Exos) are an essential class of extracellular vesicles enriched with a wide range of biologically active molecules, which gives them a unique advantage in participating in intercellular signaling and communication and serving as carriers for drug delivery. Exo-based diagnostic and therapeutic strategies are currently hot topics in disease research. Owing to their naturally low immunogenicity, good biocompatibility, ability to penetrate the blood‒brain barrier (BBB), and engineered modifications, exos have significant advantages and possible applications in the treatment of nervous system diseases. Due to the serious harm of neurological diseases to human health, they have been widely studied by researchers. Exos can be administered in a variety of ways, including intranasal administration, intracranial administration, local stereotactic injection, and encapsulation in biomaterials, each of which has its own advantages and disadvantages. However, several requirements need to be met before exo-based therapies can be implemented, such as the standardization of isolation and purification techniques, an in-depth understanding of the mechanism of action, and safety assessments and regulation for clinical translation. The aim of this review is to provide a comprehensive overview of the biogenesis, molecular composition, function, and delivery modes of exos and their therapeutic roles and mechanisms in neurological diseases (e.g., multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and stroke) and to discuss the current challenges and future perspectives to support ongoing research and clinical applications.